samy lamouille
Virginia Tech Carilion Research Institute
Roanoke, United States
Review Editor
Cancer Molecular Targets and Therapeutics
- Frontiers in Oncology
- Cancer Molecular Targets and Therapeutics
- Editorial Board
Type at least 3 characters
669 editors
Shape the future of research in your field
Join the board
Editors
Review Editors
martin lang
Institute for Biomedicine, Eurac Research
Bolzano, Italy
Review Editor
Cancer Molecular Targets and Therapeutics
young lee
Altimmune Inc.
Gaithersburg, United States
Review Editor
Cancer Molecular Targets and Therapeutics
calum leitch
University of Bergen
Bergen, Norway
Review Editor
Cancer Molecular Targets and Therapeutics
chang li
University of Washington
Seattle, United States
Review Editor
Cancer Molecular Targets and Therapeutics
chaohao li
University of Kentucky
Lexington, United States
Review Editor
Cancer Molecular Targets and Therapeutics
fei li
Nanchang University
Nanchang, China
Review Editor
Cancer Molecular Targets and Therapeutics
jinyang li
The Rockefeller University
New York City, United States
Review Editor
Cancer Molecular Targets and Therapeutics
liwen li
Indiana University
Bloomington, United States
Review Editor
Cancer Molecular Targets and Therapeutics
maolan li
Department of Biliary-Pancreatic Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University
Shanghai, China
Review Editor
Cancer Molecular Targets and Therapeutics
shangze li
Chongqing University
Chongqing, China
Review Editor
Cancer Molecular Targets and Therapeutics
siming li
Beijing Cancer Hospital, Peking University
Beijing, China
Review Editor
Cancer Molecular Targets and Therapeutics
xiaoman li
Nanjing University of Chinese Medicine
Nanjing, China
Review Editor
Cancer Molecular Targets and Therapeutics
yi li
Kunming General Hospital of Chengdu Military Command
Kunming, China
Review Editor
Cancer Molecular Targets and Therapeutics
zhiguo li
University of Kentucky
Lexington, United States
Review Editor
Cancer Molecular Targets and Therapeutics
sida liao
TScan Therapeutics, Inc
Boston, United States
Review Editor
Cancer Molecular Targets and Therapeutics